The global market for Smallpox Treatment is estimated at US$65.5 Million in 2023 and is projected to reach US$73.7 Million by 2030, growing at a CAGR of 1.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Global Smallpox Treatment Market]( "Global Smallpox Treatment Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Antiviral Drugs segment, which is expected to reach US$32.5 Million by 2030 with a CAGR of a 1.6%. The Vaccinations segment is also set to grow at 2.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $17.8 Million in 2023, and China, forecasted to grow at an impressive 3.0% CAGR to reach $13.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Smallpox Treatment Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Smallpox Treatment Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Smallpox Treatment Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Bavarian Nordic AS, Chimerix, Inc., Emergent BioSolutions Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 86 Featured):
- Bavarian Nordic AS
- Chimerix, Inc.
- Emergent BioSolutions Inc.
- Emergex Vaccines
- EpiVax, Inc.
- Oncovir, Inc.
- Pfizer, Inc.
- Sanofi SA
- SIGA Technologies Inc
- Tonix Pharmaceuticals Holding Corp.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
- Smallpox Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
3. MARKET TRENDS & DRIVERS
- Increasing Global Health Security Initiatives Drive Demand for Smallpox Treatments
- Technological Advancements in Vaccine Storage and Stability
- Emergence of Drug-Resistant Smallpox Strains Spurs Innovation
- Enhancements in Vaccine Delivery Methods Propel Market Growth
- Rise in Bioterrorism Threats Catalyzing Smallpox Preparedness
- Collaborations between Governments and Pharmaceutical Companies
- Advancements in Diagnostic Techniques Boosting Treatment Efficacy
- Global Health Organizations' Focus on Eradication Programs
- Funding Increases for Infectious Disease Research and Development
- Integration of AI in Epidemiological Predictions and Vaccine Development
- Regulatory Fast-Tracking of Critical Smallpox Medications
- Ethical and Legal Challenges in Vaccine Deployment
- Global Health Organizations Focus on Eradication Programs
- Public Awareness and Education Campaigns Impact on Treatment Uptake
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Smallpox Treatment Market Analysis of Annual Sales in US$ for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Smallpox Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Smallpox Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Smallpox Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for Antiviral Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Vaccinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for Vaccinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for Vaccinations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Supportive Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Supportive Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Supportive Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
UNITED STATES
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 20: USA Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 22: USA 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 23: USA Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 25: USA 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
- TABLE 26: Canada Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 28: Canada 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 29: Canada Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 30: Canada Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 31: Canada 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 32: Japan Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 34: Japan 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 35: Japan Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 36: Japan Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 37: Japan 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 38: China Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 39: China Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 40: China 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 41: China Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 42: China Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 43: China 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 44: Europe Recent Past, Current & Future Analysis for Smallpox Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Smallpox Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 46: Europe 16-Year Perspective for Smallpox Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 50: Europe Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 52: Europe 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 53: France Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 54: France Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 55: France 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 56: France Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 57: France Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 58: France 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 59: Germany Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 61: Germany 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 62: Germany Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 63: Germany Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 64: Germany 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
- TABLE 65: Italy Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 67: Italy 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 68: Italy Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 69: Italy Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 70: Italy 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 71: UK Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 73: UK 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 74: UK Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 75: UK Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 76: UK 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
- TABLE 77: Spain Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 78: Spain Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 79: Spain 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 80: Spain Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 81: Spain Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 82: Spain 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
- TABLE 83: Russia Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 84: Russia Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 85: Russia 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 86: Russia Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 87: Russia Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 88: Russia 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of Europe Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of Europe 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 93: Rest of Europe Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 94: Rest of Europe 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Smallpox Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 96: Asia-Pacific Historic Review for Smallpox Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 97: Asia-Pacific 16-Year Perspective for Smallpox Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 99: Asia-Pacific Historic Review for Smallpox Treatment by Treatment Type - Antiviral Drugs, Vaccinations and Supportive Care Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 100: Asia-Pacific 16-Year Perspective for Smallpox Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Vaccinations and Supportive Care for the Years 2014, 2024 & 2030
- TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 102: Asia-Pacific Historic Review for Smallpox Treatment by End-Use - Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 103: Asia-Pacific 16-Year Perspective for Smallpox Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
LATIN AMERICA
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
MIDDLE EAST
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
- Smallpox Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Companies Mentioned
- Bavarian Nordic AS
- Chimerix, Inc.
- Emergent BioSolutions Inc.
- Emergex Vaccines
- EpiVax, Inc.
- Oncovir, Inc.
- Pfizer, Inc.
- Sanofi SA
- SIGA Technologies Inc
- Tonix Pharmaceuticals Holding Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 65.5 Million |
| Forecasted Market Value ( USD | $ 73.7 Million |
| Compound Annual Growth Rate | 1.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
